Trilantic North America announced it will make a growth investment in SOFIE Biosciences. 

SOFIE, founded in 2008 and based in Dulles, Virginia, is a radiopharmacy and contract development and manufacturing organization.

Trilantic Capital Management (Trilantic North America), founded in 2009 and based in New York, is a growth-focused middle market private equity firm that

June 27, 2024

Download slides

McGuireWoods latest installment of its bimonthly brown-bag lunch series that explores important topics affecting the consumer product and retail industries. This webinar covers cannabis industry news and speakers answer questions from attendees..

McGuireWoods Speakers

Tenex Capital Management has acquired Behavioral Innovations (BI) from Shore Capital Partners, according to a news release.

BI, founded in 2000 and based in Dallas, is provider of center-based applied behavior analysis therapy to early intervention children with autism spectrum disorder and other related developmental disabilities. BI operates nearly 80 centers across Texas,

On June 6, 2024, the Supreme Court issued its opinion in Truck Insurance Exchange v. Kaiser Gypsum Co., No. 22-1079, conferring broad standing to debtors’ pre-bankruptcy liability insurers to appear and be heard in Chapter 11 bankruptcy proceedings. The ruling eliminates the “insurance neutrality” doctrine that previously constrained the participation of insurers in Chapter 11, greatly expanding insurers’ capacity to influence the reorganization process.

Council Capital has announced an investment in Allegiant Managed Care.

Allegiant, founded in 1992 and based in Pittsburgh, Pennsylvania, provides vocational and nurse case management services to insurance carriers and third-party administrators across 20 states east of the Mississippi. 

Council Capital, based in Nashville, Tennessee, focuses exclusively on lower middle market healthcare companies.

Private equity investment in the medical environment is nothing new. But what investment considerations and challenges are specific to pediatric practices?

In this episode of The Corner Series, McGuireWoods’ Geoff Cockrell is joined by Tucker Moore and Chris O’Dekirk of Concierge Capital Advisory to discuss trends and issues related to private equity involvement

On May 22, 2024, the Department of Justice’s National Security Division (“NSD”) announced its first declination of prosecution for a company under the voluntary self-disclosure program established by the National Security Division Enforcement Policy for Business Organizations (“NSD Enforcement Policy”). An individual who worked for a United States-based biochemical company, along with his co-conspirator, each pleaded guilty to one count of wire fraud conspiracy for their roles in a scheme to fraudulently obtain deeply discounted products from the company to then export those products to China using falsified export documents.   The company promptly disclosed the suspicious activity and complied with the NSD Enforcement Policy, which creates a presumption for companies to receive non-prosecution agreements when they (1) voluntarily disclose to NSD potentially criminal violations arising out of or relating to the enforcement of export control or sanctions laws; (2) fully cooperate; and (3) timely and appropriately remediate.